South Africa Advanced Therapy Medicinal Products Cdmo Market Size & Outlook

The advanced therapy medicinal products cdmo market in South Africa is expected to reach a projected revenue of US$ 125.8 million by 2030. A compound annual growth rate of 16.2% is expected of South Africa advanced therapy medicinal products cdmo market from 2025 to 2030.
Revenue, 2024 (US$M)
$51.1
Forecast, 2030 (US$M)
$125.8
CAGR, 2025 - 2030
16.2%
Report Coverage
South Africa

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

South Africa advanced therapy medicinal products cdmo market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

South Africa advanced therapy medicinal products cdmo market highlights

  • The South Africa advanced therapy medicinal products cdmo market generated a revenue of USD 51.1 million in 2024 and is expected to reach USD 125.8 million by 2030.
  • The South Africa market is expected to grow at a CAGR of 16.3% from 2025 to 2030.
  • In terms of segment, gene therapy was the largest revenue generating product in 2024.
  • Cell Therapy is the most lucrative product segment registering the fastest growth during the forecast period.


Advanced therapy medicinal products cdmo market data book summary

Market revenue in 2024USD 51.1 million
Market revenue in 2030USD 125.8 million
Growth rate16.3% (CAGR from 2025 to 2030)
Largest segmentGene therapy
Fastest growing segmentCell Therapy
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationGene Therapy, Cell Therapy, Tissue Engineered, Others (Combined ATMPs, for example biodegradable matric or scaffold)
Key market players worldwideAGC Inc, Catalent Inc, Lonza Group Ltd, Wuxi AppTec Co Ltd, Cencora Inc, Resonac Holdings Corp, Thermo Fisher Scientific Inc, CELONIC, Bio Elpida, CGT Catapult, Rentschler Biopharma SE


Other key industry trends

  • In terms of revenue, South Africa accounted for 0.8% of the global advanced therapy medicinal products cdmo market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, South Africa advanced therapy medicinal products cdmo market is projected to lead the regional market in terms of revenue in 2030.
  • South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 125.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Advanced Therapy Medicinal Products CDMO Market Companies

Name Profile # Employees HQ Website
Rentschler Biopharma SE View profile 501-1000 Laupheim, Baden-Wurttemberg, Germany, Europe https://www.rentschler-biopharma.com
CGT Catapult View profile 251-500 London, England, United Kingdom, Europe https://ct.catapult.org.uk
Bio Elpida View profile 11-50 Lyon, Rhone-Alpes, France, Europe http://www.bio-elpida.com
CELONIC View profile 251-500 Basel, Basel-Stadt, Switzerland, Europe http://www.celonic.com
Resonac Holdings Corp View profile 23840 1-9-1, Higashi-Shimbashi, Tokyo Shiodome Building, Minato-ku, Tokyo, Japan, 105-7325 https://www.resonac.com
Cencora Inc View profile 46000 1 West First Avenue, Conshohocken, PA, United States, 19428-1800 https://www.cencora.com
Catalent Inc View profile 17219 14 Schoolhouse Road, Somerset, NJ, United States, 08873 https://www.catalent.com
AGC Inc View profile 61671 1-5-1, Marunouchi, Chiyoda-ku, Tokyo, Japan, 100-8405 https://www.agc.com
Wuxi AppTec Co Ltd View profile 41116 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 https://www.wuxiapptec.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Lonza Group Ltd View profile 18000 Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 https://www.lonza.com

South Africa advanced therapy medicinal products cdmo market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to advanced therapy medicinal products cdmo market will help companies and investors design strategic landscapes.


Gene therapy was the largest segment with a revenue share of 56.16% in 2024. Horizon Databook has segmented the South Africa advanced therapy medicinal products cdmo market based on gene therapy, cell therapy, tissue engineered, others (combined atmps, for example biodegradable matric or scaffold) covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to South Africa advanced therapy medicinal products cdmo market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Africa advanced therapy medicinal products cdmo market databook

  • Our clientele includes a mix of advanced therapy medicinal products cdmo market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Africa advanced therapy medicinal products cdmo market , including forecasts for subscribers. This country databook contains high-level insights into South Africa advanced therapy medicinal products cdmo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Africa advanced therapy medicinal products cdmo market size, by product, 2018-2030 (US$M)

South Africa Advanced Therapy Medicinal Products CDMO Market Outlook Share, 2024 & 2030 (US$M)

South Africa advanced therapy medicinal products cdmo market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online